CORVUS PHARMACEUTICALS, INC

Organization

BURLINGAME, CA, US

Ticker Symbols

NASDAQ:CRVS

PHARMACEUTICAL PREPARATIONS
Business Address
863 MITTEN ROAD SUITE 102 BURLINGAME CA 94010 (650) 900-4520
Mailing Address
863 MITTEN ROAD SUITE 102 BURLINGAME CA 94010
State Location
CA
State of Incorporation
DE

Organizations

Please log in for detailed analytics

Patents Grantslast 30 patents

Information Patent Grant
Methods for detecting and treating cancers having adenosine pathway...
- Patent number 12,116,635
- Issue date Oct 15, 2024
- CORVUS PHARMACEUTICALS, INC.
- Stephen Willingham
- G01 - MEASURING TESTING
Information Patent Grant
Methods of treating cancer
- Patent number 12,023,337
- Issue date Jul 2, 2024
- CORVUS PHARMACEUTICALS, INC.
- Stephen Willingham
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Grant
Compounds and methods for modulating Interleukin-2-inducible T-cell...
- Patent number 11,897,874
- Issue date Feb 13, 2024
- CORVUS PHARMACEUTICALS, INC.
- Ryan Hudson
- C07 - ORGANIC CHEMISTRY
Information Patent Grant
Humanized anti-CD73 antibodies
- Patent number 11,859,007
- Issue date Jan 2, 2024
- CORVUS PHARMACEUTICALS, INC.
- Emily Piccione Griffin
- G01 - MEASURING TESTING
Information Patent Grant
Pharmaceutical formulations
- Patent number 11,266,649
- Issue date Mar 8, 2022
- CORVUS PHARMACEUTICALS, INC.
- Jingrong Xu
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Grant
Compounds and methods for modulating adenosine A2B receptor and ade...
- Patent number 11,254,686
- Issue date Feb 22, 2022
- CORVUS PHARMACEUTICALS, INC.
- Zhihong Li
- C07 - ORGANIC CHEMISTRY
Information Patent Grant
Methods of treating cancer
- Patent number 11,040,040
- Issue date Jun 22, 2021
- CORVUS PHARMACEUTICALS, INC.
- Andrew Hotson
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Grant
Compounds and methods for modulating interleukin-2-inducible t-cell...
- Patent number 11,008,314
- Issue date May 18, 2021
- CORVUS PHARMACEUTICALS, INC.
- Ryan Hudson
- C07 - ORGANIC CHEMISTRY
Information Patent Grant
Methods of treating cancer
- Patent number 10,912,776
- Issue date Feb 9, 2021
- CORVUS PHARMACEUTICALS, INC.
- Stephen Willingham
- C07 - ORGANIC CHEMISTRY
Information Patent Grant
Compounds and methods for modulating bruton's tyrosine kinase
- Patent number 10,870,652
- Issue date Dec 22, 2020
- CORVUS PHARMACEUTICALS, INC.
- Ryan Hudson
- C07 - ORGANIC CHEMISTRY
Information Patent Grant
Humanized anti-CD73 antibodies
- Patent number 10,822,426
- Issue date Nov 3, 2020
- CORVUS PHARMACEUTICALS, INC.
- Emily Piccione Griffin
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Grant
Anti-CD73 antibodies
- Patent number 10,793,636
- Issue date Oct 6, 2020
- CORVUS PHARMACEUTICALS, INC.
- Emily Piccione Griffin
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Grant
Processes for making triazolo[4,5D] pyramidine derivatives and inte...
- Patent number 10,654,825
- Issue date May 19, 2020
- CORVUS PHARMACEUTICALS, INC.
- Kolbot By
- C07 - ORGANIC CHEMISTRY

Please log in for detailed analytics

Patents Applicationslast 30 patents

Information Patent Application
COMPOUNDS AND METHODS FOR MODULATING INTERLEUKIN-2-INDUCIBLE T-CELL...
- Publication number 20240383884
- Publication date Nov 21, 2024
- Corvus Pharmaceuticals, Inc.
- Ryan Hudson
- C07 - ORGANIC CHEMISTRY
Information Patent Application
ANTI-CD73 COMPOUNDS TO TREAT ONCOVIRUS-POSITIVE CANCERS
- Publication number 20240301082
- Publication date Sep 12, 2024
- Corvus Pharmaceuticals, Inc.
- Richard A. Miller
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Application
IMMUNOMODULATORY ANTI-CD73 ANTIBODIES AND USES THEREOF
- Publication number 20240218073
- Publication date Jul 4, 2024
- Corvus Pharmaceuticals, Inc.
- Andrew Hotson
- C07 - ORGANIC CHEMISTRY
Information Patent Application
COMPOUNDS AND METHODS FOR MODULATING INTERLEUKIN-2-INDUCIBLE T-CELL...
- Publication number 20220363676
- Publication date Nov 17, 2022
- Corvus Pharmaceuticals, Inc.
- Ryan Hudson
- C07 - ORGANIC CHEMISTRY
Information Patent Application
B-CELL ACTIVATING CD73 ANTIBODIES
- Publication number 20220242963
- Publication date Aug 4, 2022
- Corvus Pharmaceuticals, Inc.
- Emily Piccione GRIFFIN
- C07 - ORGANIC CHEMISTRY
Information Patent Application
HUMANIZED ANTI-CD73 ANTIBODIES
- Publication number 20210253727
- Publication date Aug 19, 2021
- Corvus Pharmaceuticals, Inc.
- Emily Piccione Griffin
- G01 - MEASURING TESTING
Information Patent Application
METHODS FOR DETECTING AND TREATING CANCERS HAVING ADENOSINE PATHWAY...
- Publication number 20210255190
- Publication date Aug 19, 2021
- Corvus Pharmaceuticals, Inc.
- Stephen Willingham
- G01 - MEASURING TESTING
Information Patent Application
METHODS FOR DETECTING AND TREATING CANCERS HAVING ADENOSINE PATHWAY...
- Publication number 20210254178
- Publication date Aug 19, 2021
- Corvus Pharmaceuticals, Inc.
- Stephen Willingham
- G01 - MEASURING TESTING
Information Patent Application
ANTI-CD73 ANTIBODIES
- Publication number 20210221905
- Publication date Jul 22, 2021
- Corvus Pharmaceuticals, Inc.
- Emily Piccione Griffin
- C07 - ORGANIC CHEMISTRY
Information Patent Application
METHODS OF TREATING CANCER
- Publication number 20210154199
- Publication date May 27, 2021
- Corvus Pharmaceuticals, Inc.
- Stephen Willingham
- C07 - ORGANIC CHEMISTRY
Information Patent Application
METHODS FOR TREATING CD73HI TUMORS
- Publication number 20210107989
- Publication date Apr 15, 2021
- Corvus Pharmaceuticals, Inc.
- Emily Piccione GRIFFIN
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Application
PHARMACEUTICAL FORMULATIONS
- Publication number 20210060020
- Publication date Mar 4, 2021
- Corvus Pharmaceuticals, Inc.
- Jingrong Xu
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Application
ADENOSINE PATHWAY INHIBITORS FOR CANCER TREATMENT
- Publication number 20210008206
- Publication date Jan 14, 2021
- Corvus Pharmaceuticals, Inc.
- Richard A. Miller
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Application
METHODS OF TREATING CANCER
- Publication number 20200297728
- Publication date Sep 24, 2020
- Corvus Pharmaceuticals, Inc.
- Andrew Hotson
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Application
COMBINATION THERAPY FOR CANCER TREATMENT
- Publication number 20200261462
- Publication date Aug 20, 2020
- Corvus Pharmaceuticals, Inc.
- Richard A. Miller
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Application
COMPOUNDS AND METHODS FOR MODULATING ADENOSINE A2B RECEPTOR AND ADE...
- Publication number 20200079793
- Publication date Mar 12, 2020
- Corvus Pharmaceuticals, Inc.
- Zhihong Li
- C07 - ORGANIC CHEMISTRY
Information Patent Application
COMPOUNDS AND METHODS FOR MODULATING INTERLEUKIN-2-INDUCIBLE T-CELL...
- Publication number 20190375743
- Publication date Dec 12, 2019
- Corvus Pharmaceuticals, Inc.
- Ryan HUDSON
- C07 - ORGANIC CHEMISTRY
Information Patent Application
PHARMACEUTICAL FORMULATIONS
- Publication number 20190231783
- Publication date Aug 1, 2019
- Corvus Pharmaceuticals, Inc.
- Jingrong Xu
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Application
COMPOUNDS AND METHODS FOR MODULATING BRUTON'S TYROSINE KINASE
- Publication number 20190106423
- Publication date Apr 11, 2019
- Corvus Pharmaceuticals, Inc.
- Ryan HUDSON
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Application
HUMANIZED ANTI-CD73 ANTIBODIES
- Publication number 20190077873
- Publication date Mar 14, 2019
- Corvus Pharmaceuticals, Inc.
- Emily Piccione Griffin
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Application
METHODS OF TREATING CANCER
- Publication number 20190076433
- Publication date Mar 14, 2019
- Corvus Pharmaceuticals, Inc.
- Stephen Willingham
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Application
METHODS OF TREATING CANCER
- Publication number 20190022096
- Publication date Jan 24, 2019
- Corvus Pharmaceuticals, Inc.
- Stephen Willingham
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Application
PROCESSES FOR MAKING TRIAZOLO[4,5D] PYRAMIDINE DERIVATIVES AND INTE...
- Publication number 20180290999
- Publication date Oct 11, 2018
- Corvus Pharmaceuticals, Inc.
- Kolbot By
- C07 - ORGANIC CHEMISTRY

Please log in for detailed analytics

Trademarklast 30 trademarks

Information Trademark
88555167 - ADENOSIG
- Serial number 88555167
- Filing date Jul 31, 2019
- CORVUS PHARMACEUTICALS, INC.
- 5 - Pharmaceutical and veterinary preparations

CORVUS PHARMACEUTICALS, INC

Organization

Ticker Symbols

Business Address

Mailing Address

State Location

State of Incorporation

Patents Grantslast 30 patents

Methods for detecting and treating cancers having adenosine pathway...

Methods of treating cancer

Compounds and methods for modulating Interleukin-2-inducible T-cell...

Humanized anti-CD73 antibodies

Pharmaceutical formulations

Compounds and methods for modulating adenosine A2B receptor and ade...

Methods of treating cancer

Compounds and methods for modulating interleukin-2-inducible t-cell...

Methods of treating cancer

Compounds and methods for modulating bruton's tyrosine kinase

Humanized anti-CD73 antibodies

Anti-CD73 antibodies

Processes for making triazolo[4,5D] pyramidine derivatives and inte...

Patents Applicationslast 30 patents

COMPOUNDS AND METHODS FOR MODULATING INTERLEUKIN-2-INDUCIBLE T-CELL...

ANTI-CD73 COMPOUNDS TO TREAT ONCOVIRUS-POSITIVE CANCERS

IMMUNOMODULATORY ANTI-CD73 ANTIBODIES AND USES THEREOF

COMPOUNDS AND METHODS FOR MODULATING INTERLEUKIN-2-INDUCIBLE T-CELL...

B-CELL ACTIVATING CD73 ANTIBODIES

HUMANIZED ANTI-CD73 ANTIBODIES

METHODS FOR DETECTING AND TREATING CANCERS HAVING ADENOSINE PATHWAY...

METHODS FOR DETECTING AND TREATING CANCERS HAVING ADENOSINE PATHWAY...

ANTI-CD73 ANTIBODIES

METHODS OF TREATING CANCER

METHODS FOR TREATING CD73HI TUMORS

PHARMACEUTICAL FORMULATIONS

ADENOSINE PATHWAY INHIBITORS FOR CANCER TREATMENT

METHODS OF TREATING CANCER

COMBINATION THERAPY FOR CANCER TREATMENT

COMPOUNDS AND METHODS FOR MODULATING ADENOSINE A2B RECEPTOR AND ADE...

COMPOUNDS AND METHODS FOR MODULATING INTERLEUKIN-2-INDUCIBLE T-CELL...

PHARMACEUTICAL FORMULATIONS

COMPOUNDS AND METHODS FOR MODULATING BRUTON'S TYROSINE KINASE

HUMANIZED ANTI-CD73 ANTIBODIES

METHODS OF TREATING CANCER

METHODS OF TREATING CANCER

PROCESSES FOR MAKING TRIAZOLO[4,5D] PYRAMIDINE DERIVATIVES AND INTE...

Trademarklast 30 trademarks

88555167 - ADENOSIG